
Impact of Primary Chronic Immune Thrombocytopenia and Thrombopoietin Receptor Agonists Treatment Instructions on Daily ...
Introduction Immune thrombocytopenia (ITP) is a rare autoimmune disorder resulting from the destruction and impaired production of platelets.1,2 Although current guidelines still categorize ITP by disease duration (newly diagnosed [0–3 months], persistent …